Find company announcements below, or check out the latest news in the right side menu.
12. June 2006
Novozymes takes over UK company Delta Biotechnology Ltd, and thus strengthening its position in ingredients for the biopharmaceutical industry.
9. May 2006
In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B.
4. May 2006
26. April 2006
Novozymes made a good start to 2006, with growth of 14% in operating profit and 11% in sales. Outlook for 2006 is maintained.
2. March 2006
The annual meeting of shareholders of Novozymes A/S was held yesterday. The annual meeting adopted the report on the company's activities over the last financial year.
22. February 2006
21. February 2006
9. February 2006
8. February 2006
In accordance with Section 28a of the Danish Securities Act, Novozymes reports the following transactions under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B.
6. February 2006
3. February 2006
24. January 2006
2005 was another good year for Novozymes. Growth in both operating profit and net profit was 11% - significantly higher than expected at the beginning of the year.
20. December 2005
In connection with the Group financial statement for 2003 published on January 29, 2004, Novozymes launched a major share buy-back programme worth a total of DKK 2.5 billion over the following three to four years.
10. November 2005
In accordance with Section 37 of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B:
27. October 2005
Operating profit rose by 9%, and net profit by 14%. Outlook for operating profit, net profit and free cash flow for the year to be adjusted upwards. Share buy-backs for 2005 to be increased by DKK 200 million to DKK 1,050 million.
13. October 2005
The internationally renowned scientific journal "Nature" publishes in today’s issue an article about plectasin, which is a great acknowledgement of the work carried out within the research project.
6. September 2005
In accordance with Section 37 of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DKK0010272129, Novozymes B shares under the symbol NZYM B:
29. August 2005
Novozymes A/S purchases B shares worth DKK 244 million from Novo A/S as part of the ongoing share buy-back programme
22. August 2005
18. August 2005
16. August 2005
11. August 2005
Operating profit rose by 15%, while net profit rose by 26% compared with the first half of 2004. Outlook for the full year improved. Share buy-backs in 2005 to be increased by DKK 200 million to DKK 850 million.
1. July 2005
As stated in stock exchange announcement no. 20/2005, a reduction of Novozymes' share capital was approved at the Novozymes A/S annual general meeting on March 16, 2005.
10. June 2005
7. June 2005
25. April 2013
1. April 2013
| Copyright © 2010 Novozymes. All Rights Reserved.